Organ-like culture key factor R-spondin 1 as well as preparation method and application thereof

Through the construction and optimization of the expression system of E. coli BL21 (DE3) strain, the problem of high cost and low yield of R-Spondin 1 in mammalian cell lines was solved, and the preparation of R-Spondin 1 with high purity and high yield was achieved, which is suitable for class Organ culture.

CN118978583AInactive Publication Date: 2024-11-19JIANGSU KEYGEN BIOTECH CORP LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411459262.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-18
Publication Date
2024-11-19
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

In the prior art, the use of mammalian cell lines to prepare recombinant human R-Spondin 1 proteins has problems of high cost and low yield, and it is difficult to meet the needs of organoid culture.

Method used

E. coli BL21 (DE3) strain expression system was used to construct and optimize nucleic acid sequences, combine NcoI and XhoI cleavage sites, and recombinant plasmid transformation was performed using pET-28a(+) plasmid to induce protein expression, and pass His-tag Affinity chromatography column was purified to obtain high purity and high yield R-Spondin 1.

Benefits of technology

It has achieved efficient expression and purification of R-Spondin 1, with a purity of more than 95%, an expression amount of up to 1280mg/L or above, a lower cost, simple operation, and suitable for large-scale production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118978583A_ABST
    Figure CN118978583A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of biology, and discloses an organoid culture key factor R-spondin 1 and a preparation method and application thereof.The method comprises the steps that nucleic acid used for preparing the key factor R-spondin 1 is constructed, the nucleic acid is optimized, then the nucleic acid is connected with plasmid through enzyme digestion, recombinant plasmid is obtained and converted into an escherichia coli BL21 (DE3) strain, and the recombinant plasmid is obtained through culture. The key factor R-spondin 1 for culturing the organoid is obtained and is used for culturing the human colon organoid.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention specifically relates to a key factor R-spondin 1 for organoid culture and a preparation method and application thereof, and belongs to the field of biotechnology. Background Art

[0002] Spondin 1 belongs to the Rspo family of Wnt regulators, which currently consists of four structurally related secreted ligands, Rspo 1-4, all of which contain a furin-like domain and a thrombospondin domain. Rspo-1 is expressed in certain regions of the developing central nervous system as well as in the adrenal glands, ovaries, testes, thyroid gland, and trachea. Rspo interacts with the Frizzled / LRP6 receptor complex by stimulating the Wnt / β-catenin signaling pathway.

[0003] Organoids have broad application prospects in many fields such as stem cells and development, regenerative medicine, disease research, drug development and precision medicine. At present, studies have shown that organoids cultured in vitro can be cultured continuously for several weeks without passaging. R-spondin 1, as an activator of the classical Wnt signaling pathway, is a key component of organoid culture medium and supports sustainable long-term culture of organoids. By expressing R-Spondin 1 in large quantities, stable and high-purity protein samples can be provided, which is helpful for related experimental research, drug screening and clinical trials. People produce R-Spondin 1 through recombinant technology to study its signal transduction process and potential therapeutic value. At present, commercial recombinant human R-Spondin 1 protein is mainly derived from CHO cells and HEK293 cell lines. The main disadvantages of using mammalian cell lines for production are high cost and low yield. Summary of the invention

[0004] In order to overcome the existing deficiencies, the present invention provides a method for preparing R-spondin 1, a key factor for organoid culture, to obtain R-spondin 1, a key factor for organoid culture with better functionality and higher stability.

[0005] In order to achieve the above object, the technical solution adopted by the present invention is: In a first aspect, the present invention provides a method for preparing R-spondin 1, a key factor for organoid culture, comprising: A nucleic acid for preparing the key factor R-spondin 1 was constructed, and the nucleic acid was optimized. The optimized nucleotide sequence is shown in SEQ ID NO.4; The optimized nucleic acid and the plasmid are connected by enzyme digestion to obtain a recombinant plasmid; The recombinant plasmid was transformed into Escherichia coli BL21 (DE3) strain; The transformed Escherichia coli BL21 (DE3) strain was cultured to induce the expression of the target protein, and the key factor for organoid culture, R-spondin 1, was obtained, and its amino acid sequence is shown in SEQ ID NO.1.

[0006] In combination with the first aspect, further, the optimized nucleic acid is connected to the plasmid through two restriction sites, NcoI and XhoI, to obtain a recombinant plasmid.

[0007] Furthermore, the plasmid is pET-28a(+), and the promoter used is T7 promoter.

[0008] Further, the nucleic acid is optimized, including: An NcoI restriction site is added to the 5' end of the nucleic acid, and a stop codon and an XhoI restriction site are added to the 3' end.

[0009] Furthermore, the method further comprises: adding a poly His tag between the 3' end of the nucleic acid and the stop codon, wherein the amino acid sequence of the poly His tag is shown in SEQ ID NO:2.

[0010] Further, the recombinant plasmid is transformed into the Escherichia coli BL21 (DE3) strain including: The recombinant plasmid was mixed with BL21(DE3) competent cells and then added into LB medium; wherein the quantity ratio of BL21(DE3) competent cells to recombinant plasmid was not less than 250:1.

[0011] Further, the transformed Escherichia coli BL21 (DE3) strain was cultured, and the conditions for inducing the expression of the target protein were as follows: 25-28° C., no more than 220 rpm, and cultured for at least 12 hours.

[0012] Furthermore, after inducing the expression of the target protein, the bacteria were disrupted, separated and purified to obtain R-spondin 1, a key factor for organoid culture, which was separated and purified using a His-tag affinity chromatography column.

[0013] In a second aspect, the present invention provides a key factor for organoid culture, R-spondin 1, which is prepared by any of the methods described above.

[0014] In a third aspect, the present invention provides an application of R-spondin 1, a key factor in organoid culture, and adds R-spondin 1 for human colon organoid culture.

[0015] Compared with the prior art, the present invention has the following beneficial effects: (1) Compared with R-spondin 1 prepared using a eukaryotic expression system, the R-spondin 1 prepared using an E. coli expression system of the present invention is not only simple in method, but also can obtain a large amount of R-spondin 1 in a short time, with a purity of more than 95% and an expression level of 1280 mg / L or more; (2) The R-spondin 1 prepared by the E. coli expression system of the present invention has lower cost and higher yield; the R-spondin 1 expression and purification process is simple to operate, has good repeatability, and can be put into mass production process. BRIEF DESCRIPTION OF THE DRAWINGS

[0016] Figure 1 It is the map of plasmid pET-28a(+) provided in the embodiment of the present invention; Figure 2 is a schematic diagram of an optimized nucleic acid provided in an embodiment of the present invention; Figure 3 is an SDS-PAGE diagram of the recombinant plasmid provided in an embodiment of the present invention transformed into the Escherichia coli BL21 (DE3) strain and expressing R-Spondin 1; Figure 4 The SDS-PAGE diagram of the large-scale expression and separation of R-Spondin 1 provided in the embodiment of the present invention; Figure 5 The SDS-PAGE image of R-Spondin 1 after purification provided in the embodiment of the present invention; Figure 6 The SDS-PAGE image of R-Spondin 1 after dialysis provided in the embodiment of the present invention; Figure 7 Microscope images of R-Spondin 1 at different concentrations provided in the embodiments of the present invention applied to organoid culture. DETAILED DESCRIPTION

[0017] The present invention is further described below. The following examples are only used to more clearly illustrate the technical solution of the present invention, and are not intended to limit the protection scope of the present invention.

[0018] In view of the fact that commercial recombinant human R-spondin 1 protein is mainly derived from CHO cells and HEK293 cell lines, which leads to high cost and low yield, the present invention provides a method for preparing R-spondin 1, a key factor for organoid culture, by efficiently expressing R-spondin 1 using Escherichia coli, wherein the Escherichia coli cells are BL21 (DE3); the amino acid sequence of R-spondin 1 is shown in SEQ ID NO: 1.

[0019] The present invention provides a key factor for organoid culture, R-spondin 1, and a preparation method and application thereof, comprising the following steps: (1) Construction of a recombinant plasmid for preparing R-spondin 1; (2) Transform the recombinant plasmid into competent E. coli BL21 (DE3); (3) Expression of R-spondin 1 recombinant protein in Escherichia coli; (4) Harvesting recombinantly expressed R-spondin 1 from Escherichia coli inclusion bodies; (5) Human colon organoid culture after adding R-Spondin 1.

[0020] The coding gene of the present invention is constructed into the Escherichia coli BL21 (DE3) strain to guide the secretory expression of the N protein.

[0021] Example 1: Construction of recombinant plasmid.

[0022] The nucleotide encoding R-spondin 1 was synthesized by General Biotechnology (Anhui) Co., Ltd., and a restriction endonuclease NcoI cleavage site was added to the 5' end of the nucleotide; a stop codon TAA and a restriction endonuclease XhoI cleavage site were added to the 3' end, and a poly His tag was added to the 3' end of the synthetic nucleotide encoding R-spondin 1. The amino acid sequence of the synthetic product is shown in SEQ ID NO:3, and the nucleotide sequence is shown in SEQ ID NO:4. Figure 2 Shown is a schematic diagram of the optimized nucleic acid.

[0023] The amino acid sequence of the poly His tag is shown in SEQ ID NO:2.

[0024] The synthesized product was double-digested with restriction endonucleases NcoI and XhoI, and then subjected to agarose gel electrophoresis, and the gel was cut to recover the target fragment.

[0025] The target fragments were ligated with pET-28a(+) which was also double-digested with restriction endonucleases NcoI and XhoI to construct recombinant plasmids. Figure 1 As shown, it was named pET-28a-R-Spondin 1, His, Human.

[0026] Preferably, the promoter used is T7 promoter.

[0027] E. coli DH5α was transformed with pET-28a-R-Spondin 1, His, Human, and cultured at 37°C for 16 h before picking a single colony for plasmid extraction. The extracted plasmid was double-digested with restriction endonucleases NcoI and XhoI and then identified by agarose gel electrophoresis. The positive clones were sent to General Biotechnology (Anhui) Co., Ltd. for sequencing, and the clones with correct sequencing were selected for plasmid amplification and extraction. The extracted plasmid was sterile filtered and stored at -20°C for later use.

[0028] Example 2: The recombinant plasmid was transformed into competent E. coli BL21 (DE3) and R-Spondin 1 was expressed.

[0029] The constructed recombinant plasmid pET-28a-R-Spondin 1, His, Human was transformed into Escherichia coli competent cells BL21 (DE3) for recombinant expression of R-Spondin 1. The ratio of the number of BL21 (DE3) competent cells to the recombinant plasmid was not less than 250:1, preferably 250:1.

[0030] The plasmid was transformed into BL21 competent medium and spread on Kana-resistant plates at 37°C overnight. Then, each plate was inoculated with 1 mL of LB liquid culture medium containing Kana resistance and cultured at 37°C and 220 rpm until turbid. Sampling before induction: 1 mL of turbid bacterial solution was taken into an EP tube, centrifuged and discarded the supernatant, and 1 mL of PBS was added for standby use. A final concentration of 0.5 mM IPTG was added to the 3 tubes of culture medium and cultured at 16°C, 28°C, and 37°C for 12 hours. Then, 1 mL of the induced culture medium was taken and added to a 1.5 mL EP tube and centrifuged. The supernatant was discarded, 1 mL PBS was added and mixed. 500 μL of bacterial solution was taken from the test tube and added to a 1.5 mL centrifuge tube. Centrifuged at 6000 r / min for 5 minutes, the supernatant was removed, and the precipitate was retained. 500 μL of 1xPBS was added to each centrifuge tube, the precipitate was suspended, and the precipitate was centrifuged at 6000 r / min for 5 minutes. The supernatant was removed and the precipitate was retained. Add 400 μL of 1×PBS and 100 μL of 5×LoadingBuffer to each centrifuge tube to suspend the precipitate, and place it in a 95℃ sample cooker for 10 minutes. Take 10 μL of sample, add 3 μL of Maker, and perform SDS-PAGE identification at 180V constant voltage for 40 minutes. After the gel electrophoresis is completed, stain, decolorize, and analyze the results.

[0031] All samples were added with 10uL 5× loading buffer, incubated at 95℃ for 7min, and run on 4%-20% precast gel. Figure 3As shown, lane 1 is the untransformed whole bacteria, representing the blank control, lane 2 is the whole bacteria after induction and disruption at 16°C overnight, lane 3 is the whole bacteria after induction and disruption at 28°C overnight, and lane 4 is the whole bacteria after induction and disruption at 37°C overnight.

[0032] from Figure 3 It can be seen that R-Spondin 1 was identified as a clear target band in E. coli and was expressed at 16°C, 28°C, and 37°C. Then, it was amplified and produced at 28°C to identify whether it was expressed in inclusion bodies or supernatant, and then purified.

[0033] Example 3: Large-scale expression and isolation of R-Spondin 1.

[0034] pET-28a-R-Spondin 1, His, Human was transformed into E. coli competent BL21 (DE3), spread on LB plates with Kana resistance, and cultured at 37°C overnight. Then, a single clone colony was picked into 10mL LB (Kana 50ug / mL), cultured at 37°C overnight for 4h, transferred to 1L LB (50ug / mL), cultured until the OD value was between 0.6-0.8, 1mMIPTG was added, 25-28°C, no more than 220rpm, and cultured for at least 12h. The present invention preferably cultures at 28°C for 12h.

[0035] Collect the cultured bacterial suspension, centrifuge at 8000rpm for 10min. Discard the supernatant, add the precipitate to buffer (50mMTris, 500mM NaCl, pH7.4), stir to dissolve, and ultrasonically disrupt the bacteria. The conditions for disrupting the bacteria are: ultrasonic for 3s, pause for 5s, and ultrasonic for 30min. Keep the following 3 samples: ① Whole bacteria after disruption: take 40μL of the bacterial suspension after ultrasonication, and this sample is marked as whole bacteria after disruption; ② Supernatant after disruption: take 100μL of the bacterial suspension after disruption, centrifuge at 12000 rpm for 10 min, take 40μL of the supernatant to another EP tube, and this sample is marked as supernatant after disruption; ③ Precipitation after disruption: After the supernatant is removed, the precipitate is blown away with 40μL of Buffer (50mM Tris, 500mM NaCl, pH7.4) solution.

[0036] SDS-PAGE identification: Add 10μL of 5× Loading Buffer to each of the three samples above and place in a 95℃ sample cooker for 10 minutes. Take 10μL of each sample, add 3μL to the Maker, and perform SDS-PAGE identification at 180V constant voltage for 40 minutes. Use the untransformed BL21 bacterial solution as a blank control during identification. The results are as follows Figure 4 As shown, lane 1 is a small test control; lane 2 is the whole bacteria after disruption; lane 3 is the supernatant after disruption; lane 4 is the precipitate after disruption; M represents protein marker.

[0037] from Figure 4 It can be seen that 1L amplification can be successfully performed at 28°C, and the expression is in inclusion bodies, and the next step is to purify the inclusion bodies. The bacterial solution after ultrasonication was collected into a centrifuge tube, centrifuged at 8000rpm for 15min, the supernatant was discarded, and the precipitate was frozen at -80°C.

[0038] Example 4: This example performs the purification and renaturation of inclusion bodies of R-spondin 1, specifically comprising the following steps: Step 1: Washing of inclusion bodies.

[0039] Inclusion bodies mainly contain recombinant proteins, but also some impurities such as some outer membrane proteins, plasmid DNA, etc. These impurities will adhere to the inclusion bodies. Most of the impurities can be removed by washing, but it may not be possible to remove them completely.

[0040] In this embodiment, the precipitate was resuspended in Buffer (100 mM Tris, 1% TritonX-114, PH8.0) at a ratio of 15 mL / g and then crushed with ultrasound (ultrasound 3s, stop 6s, 60% power, 5min), and centrifuged at 4°C at high speed, 12000rpm, 30min. Repeat once. The centrifuged precipitate was resuspended in Buffer (50 mM Tris, PH 8.0) at a ratio of 20 mL / g and then crushed with ultrasound (ultrasound 3s, stop 6s, 60% power, 5min), and centrifuged at 4°C at high speed, 12000rpm, 30min. The supernatant and the precipitate were separated by centrifugation. The centrifuged precipitate was resuspended overnight in Buffer (50 mM Tris, 6M guanidine hydrochloride, PH 8.0) at a ratio of 20 mL / g. Then, it was centrifuged at 4°C at high speed, 12000rpm, 30min. The supernatant was filtered with a 0.45μm membrane for purification.

[0041] Step 2: Affinity purification of R-Spondin 1.

[0042] The present invention removes incorrectly folded R-Spondin 1 through NI column affinity purification to obtain correctly folded protein. The purification steps are as follows: 1) Column equilibration: rinse the column with ddH2O for 5CV, and then equilibrate the column with the pre-prepared Buffer (50mM Tris, 8M Urea, 300mM Nacl, PH8.0) for 5CV; adjust the UV detector transmittance (T) to 100%, and then select the appropriate range. This application selects the 0.5A range and adjusts A to 0.

[0043] 2) Sample loading: flow rate 0.5-1CV / min, peristaltic pump 1 revolution pumps out about 0.5 ml volume, 1 ml column speed set to 0.5-1rpm / min, 5 ml column speed set to 5-10rpm / min, collect the flow-through.

[0044] 3) Re-equilibration: Use buffer (50mM Tris, 8M Urea, 300mM Nacl, pH8.0) to re-equilibrate for 5CV. It is not necessary to equilibrate until the UV absorbance reaches the baseline. 4) Washing: Wash with 20 / 50 / 250 / 500mM Imidazole, and use Buffer (50mM Tris, 8M Urea, 20mM Imidazole, 300mM Nacl, PH8.0), Buffer (50mM Tris, 8M Urea, 50mMImidazole, 300mM Nacl, PH8.0), Buffer (50mM Tris, 8M Urea, 250mM Imidazole, 300mMNacl, PH8.0), and Buffer (50mM Tris, 8M Urea, 500mM Imidazole, 300mM Nacl, PH8.0) to elute the target protein step by step.

[0045] 5) Identification: Collect each component, take 5ul of the E. coli loading and flow-through components (add 15ul PBS and 5μL of 5× Loading Buffer to the sample), mix well, boil at 95℃ for 10min, take 25μL of loading, and add 3μL of Maker. Constant voltage of 180V, 40min for SDS-PAGE identification. Untransfected cells need to be brought in as blank control during identification. The results are as follows Figure 5 As shown, the target proteins are all in the elution solution. Figure 5 In the figure, lane 1 is the supernatant after inclusion body denaturation; lane 2 is the flow-through; lane 3 is 20 mM imidazole elution; lane 4 is 250 mM imidazole elution-1; lane 5 is 250 mM imidazole elution-2; lane 6 is 500 mM elution; M represents protein marker.

[0046] Step 3: Renaturation of inclusion bodies.

[0047] Renaturation refers to the process of removing denaturants under certain redox conditions so that inactive proteins can be restored to an active state through folding. The protein obtained as above was refolded in Buffer (50mM Tris, 0.5ML-arginine, 0.5M Urea, 2mM GSH, 0.4 mM GSSG, 150 mM NaCl PH8.0) at a ratio of 1:100; placed in a 4℃ refrigerator and stirred, dialyzed for 16h; the protein precipitated slightly, centrifuged at 10000rpm for 30min, and the precipitate was removed. The protein sample was refolded in Buffer (50mM Tris, 0.2M L-arginine, 0.5M Urea, 2mM GSH, 0.4 mM GSSG, 150 mM NaCl PH8.0) at a ratio of 1:100; placed in a 4℃ refrigerator and stirred, dialyzed for 16h; the protein precipitated slightly, centrifuged at 10000rpm for 30min, and the precipitate was removed.

[0048] The above renatured samples were renatured in PBS at a ratio of 1:100, placed in a 4°C refrigerator with stirring, and dialyzed for 16 hours; the protein precipitated slightly, and centrifuged at 10,000 rpm for 30 minutes to remove the precipitate. After centrifugation, filter and measure the concentration after filtration, and perform electrophoresis analysis according to the loading amount of 2ug&4ug. At this time, it is necessary to identify the morphology of the protein under both Non-Reduced and Reduced conditions, so when preparing the sample, one sample was placed in two EP tubes, and reducing and non-reducing Loading Buffer were added respectively, and SDS-PAGE electrophoresis was performed for identification. The results are as follows Figure 6 As shown, lane 1 is 2 μg of dialyzed R-Spondin 1 under reducing conditions; lane 2 is 2 μg of dialyzed R-Spondin 1 under non-reducing conditions; M represents protein marker. Figure 6 It can be seen that the size of the purified protein band is 37KDa, which is consistent with the theoretical molecular weight of the protein, and the purity is as high as over 95%, and the expression level is as high as 1280mg / L.

[0049] Example 5: Human colon organoid culture after addition of R-Spondin 1.

[0050] In this example, the obtained recombinant protein R-Spondin 1 was added to human colon organoid culture at different concentrations, and the other added factors included WNT3A, EGF and Noggin. The steps included: Step 1: Isolate human colon organoids from biopsy samples. The specific steps are as follows: 1) Thaw 100 μl of Matrigel on ice.

[0051] 2) Pre-cool D-PBS and DMEM medium supplemented with 1% BSA on ice.

[0052] 3) Place the 24-well plate in a 37°C cell culture incubator for 2 hours in advance to pre-warm.

[0053] 4) Wash the tissue sample with 10 ml of ice-cold PBS in a 15 ml centrifuge tube, wait for the sample to settle naturally for about 5 seconds, and discard the supernatant.

[0054] 5) Repeat step 4) leaving 1 ml of liquid in the tube.

[0055] 6) Use a 1 mL pipette to transfer the tissue and supernatant to a sterile 1.5 mL centrifuge tube.

[0056] 7) Use surgical scissors to cut the tissue into pieces thoroughly, transfer the tissue fragments into a new 15 mL centrifuge tube with a 1 mL pipette, and wash with PBS.

[0057] 8) Wait for the sample to settle naturally for about 5 seconds and discard the supernatant.

[0058] 9) Add 10 mL of GCDR reagent and incubate on an ice shaker for 30 min at 40 rpm. 10) Centrifuge at 290 g for 5 min and discard the supernatant.

[0059] 11) Use a 1mL pipette to draw the suspension in the tube and add it to a 70-mesh cell sieve, then filter it into a new 15mL centrifuge tube. Wash the original collection tube with 1mL DMEM+1%BSA, and collect the washing liquid through the sieve. Prepare to start intestinal organoid culture.

[0060] Step 2: Cultivate human colonic crypt organoids, as follows: 1) Count the number of crypts isolated in step 1: 2) Set the centrifugal force to 200g, centrifuge for 5 minutes, discard most of the supernatant, and retain about 100μL of the supernatant.

[0061] 3) Take out the 24-well plate from the 37°C incubator and wet the bottom of the plate with DMEM + 1% BSA using a 200 μL pipette.

[0062] 4) Add 100 μL of matrix gel to the sample tube and pipette up and down 10 times to mix the precipitate thoroughly. Be careful not to generate bubbles.

[0063] 5) Use a moistened 200 μL pipette tip to draw up 50 μL of the Matrigel crypt suspension and add one drop to one of the eight wells in the center of a 24-well plate to prepare a culture mound.

[0064] 6) Repeat step 5) until all the culture mounds are completed.

[0065] 7) Carefully transfer the culture plate to a 37°C cell culture incubator and incubate for 10 minutes to solidify the culture mound without disturbing it.

[0066] 8) Prepare 3 mL of intestinal organoid culture medium at room temperature (15-25°C). For primary culture, add 10 μL of 3 mM Y27632 (10 μM final concentration) and mix thoroughly.

[0067] 9) Gently add 750 μL of intestinal organoid culture medium to each well, making sure the tip of the pipette does not touch the culture mound.

[0068] 10) Add sterile PBS to surrounding wells.

[0069] 11) Cover the lid and incubate in a 37°C, 5% CO2 incubator.

[0070] 12) Every two days, replace the complete intestinal organoid culture medium.

[0071] 13) Passaging Step 3: Passage human intestinal organoids. The steps are as follows: 1) Pre-mix a 24-well plate in a 37°C incubator 2 hours in advance.

[0072] 2) Prepare intestinal organoid culture medium and pre-warm it to room temperature.

[0073] 3) Thaw Matrigel on ice. 25 μL Matrigel is required for each well.

[0074] 4) Pre-cool DMEM + 1% BSA on ice.

[0075] 5) Carefully aspirate the original culture medium in each well without disturbing the culture mound below.

[0076] 6) Add 1 mL of room temperature equilibrated GCDR solution to each well and incubate at room temperature for 1 min.

[0077] 7) After moistening a 1 mL pipette tip with GCDR reagent, use the pipette tip to completely peel off the culture mound from the bottom of the plate. Pipette the GCDR reagent up and down 2-3 times to destroy the culture mound and release the organoids, ensuring that the matrix gel is completely detached from the bottom of the plate.

[0078] 8) Without changing the pipette tip, transfer the organoid mixture to a 15 ml centrifuge tube.

[0079] 9) Add 1 mL of GCDR reagent to the original well, use the wet pipette tip to blow and suck the GCDR reagent 2-3 times to thoroughly clean the bottom of the plate, and transfer it to the 15 mL centrifuge tube in step 8.

[0080] 10) Repeat steps 7)-9).

[0081] 11) Incubate the centrifuge tube at room temperature on a shaker at 40 rpm for 10 min.

[0082] 12) Centrifuge at 290 g, 2-8°C, for 5 min; gently discard the supernatant.

[0083] 13) Add 1 mL of cold DMEM + 1% BSA to each tube. Use a wet 1 mL pipette tip to gently blow up and down the organoids under the liquid surface, making sure the tip of the pipette does not touch the tube wall or bottom.

[0084] 14) Use a 1mL pipette to draw the mixture through a 70-mesh cell sieve and collect it in a 15mL centrifuge tube. Wash the original 15mL centrifuge tube with 1mL cold DMEM + 1% BSA, pass the mixture through a 70-mesh cell sieve, and combine the filtrate.

[0085] Step 4: Microscope observation Referring to the above steps, different concentrations of R-Spondin 1 were applied to organoid culture, and experimental group 1, experimental group 2, and experimental group 3 were set up, with 4 parallel experiments in each group; the concentration of experimental group 1 was 20 ng / ml; experimental group 2 was the blank control group, with a concentration of 0 ng / ul; the concentration of experimental group 3 was 5 ng / ul.

[0086] The results under a 40x microscope are as follows Figure 7 As shown, the first line is 4 parallel tests of experimental group 1, the second line is 4 parallel tests of experimental group 2, and the third line is 4 parallel tests of experimental group 3. Figure 7 It can be seen that the number of human colon organoids increased most significantly after culture with the addition of 20ng / ml R-Spondin 1 compared to the blank.

[0087] The invention discloses a method for preparing R-Spondin 1 by using Escherichia coli. The R-Spondin 1 expression and purification process is simple to operate and has good repeatability. The obtained R-Spondin 1 has good function and stability.

[0088] SEQ ID NO:1 SRGIKGKRQRRISAEGSQACAKGCELCSEVNGCLKCSPKLFILLERNDIRQVGVCLPSCPPGYFDARNPDMNKCIKCKIEHCEACFSHNFCTKCKEGLYLHKGRCYPACPEGSSAANGTME CSSPAQCEMSEWSPWGPCSKKQQLCGFRRGSEERTRRVLHAPVGDHAACSDTKETRRCTVRRVPCPEGQKRRKGGQGRRENANRNLARKESKEAGAGSRRRKGQQQQQQGTVGPLTSAGPA SEQ ID NO:2 HHHHHH SEQ ID NO:3 SRGIKGKRQRRISAEGSQACAKGCELCSEVNGCLKCSPKLFILLERNDIRQVGVCLPSCPPGYFDARNPDMNKCIKCKIEHCEACFSHNFCTKCKEGLYLHKGRCYPACPEGSSAANGTMECSSPAQCEMSEWSPWGPCSKKQQLCGFRRGSEERTRRVLHAPVGDHAACSDTKETRRCTVRRVPCPEGQKRRKGGQGRRENANRNLARKESKEAGAGSRRRKGQQQQQQQGTVGPLTSAGPAHHHHHH SEQ ID NO:4 atgagccgtggtattaagggtaaacgtcagcgtcgtattagtgccgaaggcagtcaggcctgcgcaaaaggctgtgaactgtgtagtgaagtgaatg gttgtctgaaatgcagcccgaaactgtttattctgctggaacgtaatgatattcgccaggttggtgtttgcctgccgagttgtccgccgggttattt tgatgcccgtaatccggatatgaataagtgcattaagtgtaaaatcgagcattgcgaagcctgttttagccataatttttgtaccaaatgcaaggaa ggtctgtatctgcataaaggccgctgttatccggcctgcccggaaggtagtagcgccgcaaatggcacaatggaatgcagcagtccggcccagtgtg aaatgagcgaatggagcccgtggggcccgtgcagcaaaaaacagcagctgtgtggttttcgtcgcggcagtgaagaacgtacccgtcgtgtgctgca tgcaccggtgggcgatcatgccgcctgcagtgataccaaagaaacccgtcgttgcaccgtgcgtcgtgtgccgtgtccggaaggtcagaaacgtcgc aaaggcggtcagggtcgtcgtgaaaatgccaatcgtaatctggcacgcaaagaaagcaaagaagcaggcgccggtagtcgtcgtcgcaaaggtcagc agcagcagcaacagcagggcaccgtgggcccgctgaccagtgcaggtccggcacatcatcatcaccattaactcgagcaccaccaccaccaccac The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the technical principles of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A method for preparing R-spondin 1, a key factor for organoid culture, characterized in that: include: A nucleic acid for preparing the key factor R-spondin 1 was constructed, and the nucleic acid was optimized. The optimized nucleotide sequence is shown in SEQ ID NO.4; The optimized nucleic acid and the plasmid are connected by enzyme digestion to obtain a recombinant plasmid; The recombinant plasmid was transformed into Escherichia coli BL21 (DE3) strain; The transformed Escherichia coli BL21 (DE3) strain was cultured to induce the expression of the target protein, and the key factor for organoid culture, R-spondin 1, was obtained, and its amino acid sequence is shown in SEQ ID NO.

1.

2. The method according to claim 1, characterized in that The optimized nucleic acid was connected to the plasmid through the two restriction sites of NcoI and XhoI to obtain the recombinant plasmid.

3. The method according to claim 1, characterized in that: The plasmid is pET-28a(+), and the promoter used is T7 promoter.

4. The method according to claim 1, characterized in that: Optimization of nucleic acids, including: An NcoI restriction site is added to the 5' end of the nucleic acid, and a stop codon and an XhoI restriction site are added to the 3' end.

5. The method according to claim 4, characterized in that The method further comprises: adding a poly His tag between the 3' end of the nucleic acid and the stop codon, wherein the amino acid sequence of the poly His tag is shown in SEQ ID NO:

2.

6. The method according to claim 1, characterized in that Transforming the recombinant plasmid into the Escherichia coli BL21 (DE3) strain includes: mixing the recombinant plasmid with BL21 (DE3) competent cells and then adding LB culture medium; wherein the ratio of the number of BL21 (DE3) competent cells to the recombinant plasmid is not less than 250:

1.

7. The method according to claim 1, characterized in that The transformed E. coli BL21 (DE3) strain was cultured to induce the expression of the target protein at 25-28° C., no more than 220 rpm, and cultured for at least 12 hours.

8. The method according to claim 1, characterized in that After inducing the expression of the target protein, the bacteria were broken and separated and purified to obtain R-spondin 1, a key factor for organoid culture, which was separated and purified using a His-tag affinity chromatography column.

9. A key factor for organoid culture, R-spondin 1, characterized in that: The method is prepared by any one of claims 1 to 8.

10. An application of R-spondin 1, a key factor for organoid culture according to claim 9, characterized in that: R-Spondin 1 was added for human colon organoid culture.

Citation Information

Patent Citations

  • Culture medium for colon cancer organs and application thereof

    CN113846061A

  • Large scale organoid analysis

    US20210172931A1